Current Vascular Pharmacology
Title:Editorial (Should Chronic Kidney Disease be Considered as a Coronary Heart Disease Equivalent?)
Volume: 10 Issue: 3
Author(s): Vasilios G. Athyros, Niki Katsiki, Asterios Karagiannis and Dimitri P. Mikhailidis
Affiliation:
Keywords: Chronic kidney disease, coronary heart disease equivalent, guidelines, statins, dyslipidaemia
Export Options
About this article
Cite this article as:
G. Athyros Vasilios, Katsiki Niki, Karagiannis Asterios and P. Mikhailidis Dimitri, Editorial (Should Chronic Kidney Disease be Considered as a Coronary Heart Disease Equivalent?), Current Vascular Pharmacology 2012; 10 (3) . https://dx.doi.org/10.2174/157016112799959422
DOI https://dx.doi.org/10.2174/157016112799959422 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Advancements in Arterial Stiffness: Novel Therapeutic Frontiers
Arterial stiffness, a hallmark of cardiovascular disease, poses significant challenges in contemporary healthcare. This thematic issue delves into the multifaceted landscape of arterial stiffness and explores cutting-edge therapeutic interventions aimed at mitigating its adverse effects. Within these pages, readers will find a comprehensive overview of the mechanisms underlying arterial stiffness, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Effects of Newer Beta-Adrenoceptor Antagonists on Vascular Function in Cardiovascular Disease
Current Vascular Pharmacology Effects of Transcutaneous Electrical Nerve Stimulation in Autonomic Nervous System of Hypertensive Patients: A Randomized Controlled Trial
Current Hypertension Reviews Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease
Current Pharmaceutical Design Access to Medicines and the Safety of the People
Reviews on Recent Clinical Trials subject Index To Volume 3
Current Drug Targets Duration of Dual Antiplatelet Therapy After Coronary Stenting
Current Pharmaceutical Design Molecular Mechanisms of the Antiatherogenic Action of Adiponectin
Vascular Disease Prevention (Discontinued) Barriers to Achieving Optimal Glycemic Control in a Multi-Ethnic Society: A US Focus
Current Diabetes Reviews Pharmacological Inhibition of Platelet Reactivity. Clinical and Pharmacodynamic Effects
Current Vascular Pharmacology Total Polyphenols and Bioactivity of Seeds and Sprouts in Several Legumes
Current Pharmaceutical Design Recent Patents of Gene Sequences Relative to DNA Polymerases
Recent Patents on DNA & Gene Sequences The GH/IGF-1 Axis and Heart Failure
Current Cardiology Reviews Obesity and Inflammation – Targets for OA Therapy
Current Drug Targets Associations between Periodontitis and Systemic Inflammatory Diseases: Response to Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Recent Advances in the Comprehension and the Management of Perioperative Systemic Host Response During Cardiopulmonary Bypass
Recent Patents on Cardiovascular Drug Discovery Thrombolytic Treatment of Cardiac Myxoma-Induced Ischemic Stroke: A Review
Current Drug Safety MiR-218-5p Mediates Myocardial Fibrosis after Myocardial Infarction by Targeting CX43
Current Pharmaceutical Design Levosimendan Preoperative
Current Pharmaceutical Design Agents Complexing Copper as a Therapeutic Strategy for the Treatment of Alzheimers Disease
Current Alzheimer Research Dynamic Ventricular Repolarisation: From Physiology to Prognosis
Current Cardiology Reviews